Xiuli Liu, MD, PhD

Xiuli Liu, MD, PhD
Unit Director: 
Gastrointestinal and Liver Pathology

Xiuli Liu, MD, PhD, is a professor and the director of gastrointestinal and liver pathology at the University of Florida Department of Pathology, Immunology and Laboratory Medicine. With more than 10 years of clinical experience, Dr. Liu is an expert gastrointestinal and liver pathologist with strong clinical and translational research in Barrett’s esophagus, inflammatory diseases of the gastrointestinal tract, including inflammatory bowel disease and inflammatory bowel disease, pancreatic cancer and liver diseases.

Dr. Liu currently works in a multidisciplinary environment at UF and regularly interacts with gastroenterologists and hepatologists, as well as colorectal, hepatopancreatobiliary and transplant surgeons. Prior to this, Dr. Liu practiced internal medication for five years, in addition to working in gastrointestinal and hepatopancreatobiliary pathology at the Cleveland Clinic Department of Pathology, one of the busiest and demanding pathology departments in the United States. These combined experiences allow Dr. Liu to truly understand the clinical implication of pathologic diagnoses and guide treating physicians in selecting the most effective therapies for their patients.

An accomplished author, Dr. Liu has published more than 100 peer-reviewed articles, mostly focused on difficult and challenging entities in the gastrointestinal and hepatopancreatobiliary pathology. She has also written seven book chapters on the human esophagus; frozen interpretation of gastrointestinal specimens; and the diagnosis of inflammatory bowel disease and neoplasia, as well as colonic polyps.

Selected Publications

Some selected works from Dr. Liu’s many other publications on her studies in gastrointestinal and liver pathology, include:

  1. Horvath B, Singh P, Xie H, Thota PN, Allende D, Pai R, Patil DT, Plesec TP, Goldblum JR, Liu X. Risk for esophageal neoplasia in Barrett’s esophagus patients with mucosal changes indefinite for dysplasia. J Gastroenterol Hepatol. 30:262-267, 2015. [PMID: 25087917]. Featured on MDLinx.com
  2. Kim R, Tan A, Lai KK, Jiang J, Wang Y, Rybicki LA, and Liu X. Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer. Cancer 117: 3126-3134, 2011.
  3. Liu X, Goldblum JR, Zhao X, Landau M, Leach BH, Pai R, Lin, J. Distinct clinicohistologic features of inflammatory bowel disease-associated colorectal adenocarcinoma: in comparison to sporadic microsatellite stable and Lynch syndrome-related colorectal adenocarcinoma". Am J Surg Pathol. 36:1228-1233, 2012.
  4. Chen D, Goldblum JR, Landau M, Rice TW, Rai RK, Xiao S-Y, Liu X. Semiquantitative evaluation of a common histology pattern improves diagnosis of esophageal carcinoma cuniculatum in mucosal biopsy. Mod Pathol. 26:806-815, 2013.
Pathology Team